netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 13: Skin - Full Chapter
Notes:

Only high cost medicines to be supplied within our health economy are listed on BSW Formulary, but patients may also have access to more specialised, high cost medicines via other specialist centres, if eligible.

Dermatology-related Prescribing Guidance

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

Dermatology-related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter.

Self-care

Many of the products in this chapter are available for purchase over-the-counter, and patients are encouraged to self-care, with the support of their community pharmacist, in the first instance.

For further information on self-care & the NHS, please refer to https://www.england.nhs.uk/medicines/conditions-for-which-over-the-counter-items-should-not-routinely-be-prescribed/

Dermatology Specials Approved List: see section 13.14

Please note that any specials listed in the BAD list are deemed to be RED on this formulary, so that specialists can prescribe them only.

 

 

 Details...
13.12  Expand sub section  Antiperspirants
Aluminium Salts 
(Solution)
View adult BNF View SPC online
Formulary
Self
  • 20% aluminium chloride hexahydrate in an alcoholic basis
  • Anhydrol Forte®, 60ml         
  • Driclor® 60ml, 75ml
  • Notes: Aluminium chloride is a potent antiperspirant used in the treatment of severe hyperhidrosis.
 
   
Botulinum A toxin 
(Antiperspirant)
View adult BNF View SPC online
Formulary
Red
  • GWH.
  • A specific commissioning policy for the use of this for hyperhydrosis is under development (August 19). Current botulinum policy is found below.
  • Botulinum toxin units are not interchangeable from one product to another.  Prescribe by brand as advised by hospital pharmacy department.
 
Link  BSW CCG BOTULINUM TOXIN POLICIES
   
Glycopyrronium Bromide
(Hyperhidrosis)
View adult BNF View SPC online
Formulary
  • Various glycopyrronium products are used:
  • 1mg and 2mg tablets
  • 3g/5g/10g powder for solution for iontophoresis
  • unlicensed unlicensed: Solution 0.05% 500mL and topical cream in various strengths (0.5%-4%) (both unlicensed preparation) for use in iontophoretic threatment of hyperhydrosis
  • A specific CCG commissioning policy for the use of this for hyperhydrosis is under development (August 19).
 
   
Propantheline Bromide
(Tablets)
View adult BNF View SPC online
Formulary
Amber
  • 15mg tablets
  • Licensed for hyperhydrosis and used for gustatory sweating but only included on the formulary for this indication when initiated at GWH 
  • Not on formulary for this indication at RUH or at SFT.
  • See Chapter 1.2 for other formulary indications
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Red

RED - Hospital only to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.  

Amber

Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.  

Amber with Shared Care

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

Green

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.  

Self

Suitable for patient to be directed to buy themselves  

Grey

Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.   

Black

Not currently used. We intend to include this TLS in future to highlight where a decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.  

Red Specialist Centre

Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.  

netFormulary